Information  X 
Enter a valid email address

XTL Biopharm Ltd (XTL)

  Print      Mail a friend

Thursday 07 July, 2005

XTL Biopharm Ltd

AGM and EGM Notice Posted

XTL Biopharmaceuticals Ltd
07 July 2005


Annual General Meeting ('AGM') and Extraordinary General Meeting ('EGM') notice
posted to shareholders

Rehovot, Israel, 7 July 2005 - The Company has posted to shareholders a notice
convening its AGM and an EGM. The AGM will take place the Company's offices,
Kiryat Weizmann Science Park, Bldg 3, 3 Hasapir St, Ness Ziona 76100, Israel at
10a.m. (Israel Time) on 1 August 2005 and the EGM will follow at 4p.m. at the
same venue on the same day.

At the AGM it is proposed that:

   •the annual reports for the year ended 31 December 2004 be received;
   •Kesselman & Kesselman be reappointed as the Company's auditors;
   •Messrs Michael Weiss, Ben Zion Weiner, William Kennedy and Jonathan
    Spicehandler be reappointed as Directors of the Company;
   •Vered Shany and Ido Seltenreich be appointed as External Directors of the
    Company; and
   •the Company's articles be amended.

At the EGM it is proposed that:

   •the remuneration for non-Executive Directors be approved;
   •the grant of options to William Kennedy and Jonathan Spicehandler be
    approve;
   •the grant of options to Ben-Zion Weiner be approved;
   •the annual fee of Michael Weiss and the remaining terms of remuneration
    of Michael Weiss including the grant of options;
   •the Company's purchase of liability insurance be approved; and
   •the indemnification to the Board members be approved


Contacts:

XTLbio
Jonathan Burgin, Chief Financial Officer               Tel: +972 8 930 4440

Notes to Editors
XTL Biopharmaceuticals Ltd. (XTLbio) is a biopharmaceutical company developing
drugs against hepatitis. Established in 1993, XTLbio became a public company in
2000 and its ordinary shares are listed on the Official List of the UK Listing
Authority and are traded on the London Stock Exchange under the symbol XTL.



                      This information is provided by RNS
            The company news service from the London Stock Exchange